
Bioinicia
Bioinicia is a company with R&D and production expertise in both electrospinning and electrospraying processes.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
€690k | Grant | ||
Total Funding | 000k |
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% growth | 77 % | 49 % | 22 % | 115 % | (74 %) | - | - |
EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% EBITDA margin | 16 % | 11 % | 21 % | 14 % | 24 % | - | - |
Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
% profit margin | 6 % | 5 % | 19 % | 8 % | 11 % | - | - |
EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Bioinicia is a technology company specializing in electrospinning and electrospraying processes for developing and manufacturing nano and micro-structured materials. Founded as a spin-off from the Spanish National Research Council (CSIC), the company leverages scientific knowledge to address market needs. The CEO is José M. Lagarón.
The company operates on a dual model, acting as both a contract development and manufacturing organization (CDMO) and an equipment provider. As a CDMO, Bioinicia is the first in the world to be cGMP and ISO 13485 certified for the industrial-scale production of electrospun materials for pharmaceutical and medical applications. It serves clients from concept to commercialization in sectors including pharmaceuticals, biomedical, cosmetics, nutraceuticals, and functional foods. For instance, its Bioinicia Cosmetics brand, developed with the CSIC, creates products composed of 100% active ingredients, such as anti-wrinkle patches.
As an equipment supplier, Bioinicia designs and manufactures premium, climate-controlled electrospinning and electrospraying equipment under its Fluidnatek® and Spinbox® brands. The product line ranges from laboratory-scale R&D tools, like the Fluidnatek LE-10 and LE-100, to pilot-scale and industrial production machinery, such as the LE-500. This technology enables the production of advanced materials like nanofiber-based membranes, coatings, and encapsulated ingredients for diverse applications including filtration, affinity membranes, and textiles.
Keywords: electrospinning, electrospraying, nanofibers, nanomaterials, contract manufacturing, medical devices, GMP certified, pharmaceuticals, cosmetic ingredients, material science